CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples